Polyether antibiotics are a large class of microbial secondary metabolites generally produced by soil actinomycetes of the genus Streptomyces').
Intensive search for new polyether antibiotics has in recent years revealed that other genera of streptomycetes also produce these antibiotics. Laidlomycin is produced by Streptoverticillum eurocidium'). Cationomycin'), antibiotics CP-47,433 and CP-47,4344)
as well as CP-51,5323) are produced by strains of Actinomadura. Antibiotic CP-44,161 was isolated from the fermentation broth of a Dactylosporangium culture'). In this paper, we report the discovery of a novel polyether antibiotic complex produced by a hitherto undescribed Nocardia, strain X-14868.
Nocardia X-14868 produces a complex of antibiotics with X-14868A the major component. A second component, X-14868B, originally thought to be elaborated directly by the producing organism, was later found to be an artifact chemically derived from X-14868A during the isolation work-up process. Other minor components that have been isolated from the culture broth are antibiotic X-14868C
and X-14868D. The structure of each of these antibiotics shown in Fig. I was determined by X-ray crystallographic analysis'). This report is concerned with the taxonomy of the antibiotic producing culture, fermentation conditions for the production of the antibiotics, and the biological and ionophore properties of antibiotics X-14868A and X-14868B.
Taxonomy of the Producing Organism
The streptomycete culture producing antibiotic X-14868A and other minor antibiotic components was isolated from a beach sand sample collected in Colloroy, Australia.
The culture was designated X-14868 and has been deposited at the American Type Culture Collection, Rockville, Maryland, where it has been assigned the number ATCC 31585. Strain X-14868 has the following morphological, physiological and chemical characteristics.
Microscopic and Macroscopic Examination
Strain X-14868 cultivated on the standard ISP media (Difco) produces a substrate mycelium which fragments after several days allowing extensive mycelial development. It produces an aerial mycelium consisting of rope-like tufts but no spores were found. Table I summarizes the amount of growth, aerial mass color, color of reverse substrate mycelium and presence of any soluble pigment produced by strain X-14868 on various solid media after 4 weeks of incubation at 28°C.
Physiological Characteristics
The carbon utilization and other metabolic characteristics of strain X-14868 are shown in Tables   2 and 3 . Strain X-14868 hydrolyzed gelatin and casein but not starch. The culture was resistant to penicillin in an agar diffusion test (10 units benzylpenicillin in a ca. 6 mm disk), and when tested according to the method of GORDON'), was resistant to lysozyme (0.005;0) as well. The strain completely peptonized litmus milk (Difco) and no melanin production was detected on ISP-6 or ISP-7 medium. Table 2 . Carbon utilization on ISP-9 medium by strain X-14868.
Carbon source
No carbon control
T Negative response at 28-C after one month incubation.
_, Doubtful response. = , More growth than no carbon control but less than on glucose.
-, Positive response, equal to the amount of growth on glucose. APR. 1983 Cell Wall Analysis
The cell wall analysis of the isomer of diaminopimelic acid was performed by the method of BECKER et al.°>. For sugar content of the cell wall, the method of LECHEVALIER and LECHEVALIER10) was followed. These analyses revealed that the cell wall of X-14868 contains the meso-isomer of diaminopimelic acid as well as galactose and arabinose. Based on these morphological and physiological characteristics as well as the chemical composition of its cell wall (cell wall type IV of the classification of Actinomycetales by LECIEVALIER and LECHEVALIER10)), strain X-14868 is assigned to the genus Nocardia.
According to BERGEY'S manually, strain X-14868 can be placed in the Nocardia morphological group III with abundant mycelial development due to delayed fragmentation. This is a vague classification based only on the acid-fast heterotrophic properties of the organism. Using this scheme, the closest species would be Nocardia kuroishii. However, the carbon utilization data and many physiological properties are inconsistent with this identity. Based on the available literature on Nocardia, there is no description of a species of Nocardia resembling X-14868. However, until a comparative study of several known Nocardia species with species X-14868 is done, a new species designation will not be proposed.
Fermentation
To prepare vegetative inoculum for the production of antibiotic X-14868A and its minor compon- Biological and Ionophore Properties
The antimicrobial activity of antibiotics X-14868A, B, C, and D are shown in Table 4 . They are mainly active against Gram-positive bacteria and exhibit no activity against Gram-negative bacteria and several fungi tested. Antibiotic X-14868A is also active against Treponema h 'odysenteriae. The in vitro minimum inhibitory concentration against several strains of this organism was found to be 0.005 hg/ml. Antibiotics X-14868A and B are potent anticoccidial agents. The amount needed in feed to prevent chicken coccidiosis caused by Eitneria tenella is shown in Table 5 . These data indicate that chicken coccidiosis can be effectively controlled by antibiotic X-14868A at about 7 parts per million (ppm) and by X-14868B at 15 ppm in feed. This is an order of magnitude more active than other known coccidiostats such as monensin (approved use level 98-121 ppm)'4>, lasalocid (approved use level 75 -125 ppm)15) or salinomycin (60' 100 ppm)16).
The ionophore properties of antibiotics X-14868A and B were studied. The affinity of these antibiotics to monovalent and divalent metal cations was examined by a cation competition experiment using a two-phase system described in Table 6 . The results show that antibiotic X-14868A has the highest affinity for potassium ion and that X-14868B binds most tightly with the divalent cation, magnesium.
Based on these results, the cation selectivity sequence of these antibiotics can be summarized below:
X-14868A: K+> Rb+> Na+> Li+> Cs+ > Mg' +, Ca' +, Ba'+, Sr'+ X-14868B: Mg2+>Ca2+>Ba2+, Sr2+>Li+>K+>Rb+,Na+>Cs+ A time course of cation transport by these antibiotics in a U-tube system13), is shown in Fig. 3 .
X-14868A transports the monovalent cation rubidium effectively in this system, but the transport of divalent cation calcium is much less efficient. On the other hand, X-14868B transports both rubidium and calcium with about equal efficiency but at a slower rate compared with that of antibiotic X-14868A. The cation selectivity sequence of X-14868A and X-14868B was determined by the method described previously 17). Two umole of antibiotic (in 2 ml of 70% toluene -30% n-butanol) were equilibrated by shaking for 2 hours at 20'C with 2 ;imole of "'RbCl or 1 lnnole of "CaCl2_ (in 1 ml of dimethyl glycinetetramethylammonium hydroxide buffer, 25 mM pH 10.0). Complex formation was measured by liquid scintillation counting of both phases (see Fig. 3 ).
Displacement of labelled cation from the ionophore complexes was determined by the addition of unlabelled cations (2 umole of monovalent or 1 umole of divalent metal chloride). The U-tube system described by ASHTON and STEINRAUFI3> was employed for the assay. A glass U-tube was filled with 5 ml of a chloroform solution of antibiotic (1 x 10-' M). Two ml of an aqueous tris-HCI buffer (20 mM, pH 9.5) containing 1 mm 43CaC12 or SORbCI was placed in one arm of the U-tube and an equal volume of the same buffer solution with unlabelled calcium or rubidium chloride in the other arm. The reaction was started by the addition of the respective labelled metal chloride and the chloroform phase separating the two aqueous phases was then gently stirred with a magnetic stirrer. The rate of appearance of radioactive calcium or rubidium in the label-free side was determined by counting samples (50 pl) taken from both aqueous phases with 10 ml Aquasol (New England Nuclear, Boston, Mass.) in an Intertechnique liquid scintillation spectrometer.
It is interesting to note the striking difference in the cation binding and transporting properties of antibiotics X-14868A and B in view of the fact that these antibiotics differ only by a single methyl group (Fig. 1) . It should be noted, however, that this slight change in structure leads to a marked conformational change which, in turn, alters the cation binding property of the antibiotic. The peculiar cation binding property of antibiotic X-14868B is also reflected in the unusual 2: 1 stoichiometry found for the X-14868B: Na complex-->.
